PHARMACEUTICAL COMPOSITIONS COMPRISING PREDNISOLONE METASULFOBENZOATE AND 5-ASA FOR TREATING IBD

摘要

A stable and/or synergistic pharmaceutical composition comprising: a) prednisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium and b) 5 -ASA, derivatives or pharmaceutically acceptable salts thereof, which is suitable for rectal administration.